Concepedia

Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo state, Brazil

Karin Yamada, Clarisse Zaitz, Valéria Maria de Souza Framil, Laura Hitomi Muramatu

Revista do Instituto de Medicina Tropical de São Paulo · 2011 · 28 citations · 9 references

DOIFull text

Open access

Abstract

SSKI is an effective drug, with many side effects, but with low frequency. Resolution was for maximum six months of treatment. SSKI has been found to be a very effective drug in this retrospective study of culture-proven cases of cutaneous and lymphocutaneous sporotrichosis. It should be used as first drug of choice especially in resource-limited settings.

References

9

Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America

Carol A. Kauffman, Beatriz Bustamante, Stanley W. Chapman et al. · Clinical Infectious Diseases · 2007 · 555 citations

Sporothrix schenckii and sporotrichosis

Leila M. Lopes‐Bezerra, Armando O. Schubach, Rosane Orofino‐Costa · Anais da Academia Brasileira de Ciências · 2006 · 207 citations · Full text

, , +15

Sporotrichosis in Peru: Description of an Area of Hyperendemicity

Peter G. Pappas, Ildefonso Téllez, Akash Deep et al. · Clinical Infectious Diseases · 2000 · 196 citations · Full text

Population‐Based Surveillance and a Case‐Control Study of Risk Factors for Endemic Lymphocutaneous Sporotrichosis in Peru

G. Marshall Lyon, S. Zurita, José Casquero et al. · Clinical Infectious Diseases · 2003 · 94 citations · Full text

, , +14

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day<sup>−1</sup>) in the treatment of cutaneous or lymphocutaneous sporotrichosis

Stanley W. Chapman, Peter G. Pappas, Claude Kauffmann et al. · Mycoses · 2004 · 80 citations · Full text